PARD3 and liver cancer: The CNAs characterized as “gains” or “amplification” result in an elevated number of copies of the PARD3 gene in the cancer cells’ genome, leading to higher levels of PARD3 mRNA and protein in liver cancer cells (Fig. S9C).